Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Tuberculosis

  Free Subscription


13.01.2020

4 Am J Respir Crit Care Med
2 Antimicrob Agents Chemother
3 Clin Infect Dis
1 Emerg Infect Dis
2 Eur J Clin Microbiol Infect Dis
5 Int J Tuberc Lung Dis
1 J Infect Dis
1 Lancet Oncol
1 PLoS Med
9 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. DE JAGER VR, Vanker N, van der Merwe L, van Brakel E, et al
    Optimising beta-lactams Against Tuberculosis.
    Am J Respir Crit Care Med. 2020 Jan 10. doi: 10.1164/rccm.201911-2149.
    PubMed     Text format    

  2. VERRALL AJ, Chaidir L, Ruesen C, Apriani L, et al
    Lower BCG Protection Against Mycobacterium tuberculosis Infection After Exposure to Beijing Strains.
    Am J Respir Crit Care Med. 2020 Jan 8. doi: 10.1164/rccm.201912-2349.
    PubMed     Text format    

  3. MCSHANE H
    Controlled Human Infection Models - Is it Really Feasible to Give People Tuberculosis?
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2408.
    PubMed     Text format    

  4. LEE HS, Kee SJ, Shin JH, Kwon YS, et al
    Xpert MTB/RIF Assay as a Substitute for Smear Microscopy in an Intermediate-Burden Setting.
    Am J Respir Crit Care Med. 2019;199:784-794.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  5. ZHANG N, Strydom N, Tyagi S, Soni H, et al
    Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01727.
    PubMed     Text format     Abstract available

  6. JING W, Zong Z, Tang B, Wang J, et al
    Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01736.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  7. RENS NE, Uyl-de Groot CA, Goldhaber-Fiebert JD, Croda J, et al
    Cost-Effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis.
    Clin Infect Dis. 2020 Jan 6. pii: 5697286. doi: 10.1093/cid/ciz1212.
    PubMed     Text format     Abstract available

  8. LI R, Nordio F, Huang CC, Contreras C, et al
    Two clinical prediction tools to improve tuberculosis contact investigation.
    Clin Infect Dis. 2020 Jan 6. pii: 5697300. doi: 10.1093/cid/ciz1221.
    PubMed     Text format     Abstract available

  9. SOSSEN B, Broger T, Kerkhoff AD, Schutz C, et al
    'SILVAMP TB LAM' rapid urine tuberculosis test predicts mortality in hospitalized HIV patients in South Africa.
    Clin Infect Dis. 2020 Jan 9. pii: 5699650. doi: 10.1093.
    PubMed     Text format     Abstract available


    Emerg Infect Dis

  10. CAMPBELL JR, Falzon D, Mirzayev F, Jaramillo E, et al
    Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Text format     Abstract available


    Eur J Clin Microbiol Infect Dis

  11. DU J, Shu W, Liu Y, Wang Y, et al
    Multicenter feasibility study to assess external quality panels for molecular diagnostics for tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 3. pii: 10.1007/s10096-019-03730.
    PubMed     Text format     Abstract available

  12. SHU W, Du J, Liu Y, Wang Y, et al
    External quality control of phenotypic drug susceptibility testing for Mycobacterium tuberculosis in China.
    Eur J Clin Microbiol Infect Dis. 2020 Jan 2. pii: 10.1007/s10096-019-03770.
    PubMed     Text format     Abstract available


    Int J Tuberc Lung Dis

  13. RENDON A, Silva DR, Esposito S, Sotgiu G, et al
    Launching the Global TB Network.
    Int J Tuberc Lung Dis. 2019;23:123-124.
    PubMed     Text format    

  14. VAN AERDE KJ, van der Heijden EHFM, Henriet SS, Merkus PJ, et al
    A case promoting use of ultrasound-guided sampling techniques to correctly diagnose MDR-TB in children.
    Int J Tuberc Lung Dis. 2019;23:236-238.
    PubMed     Text format     Abstract available

  15. SULEIMAN K, England K, Lessem E, McKenna L, et al
    Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspective.
    Int J Tuberc Lung Dis. 2019;23:272.
    PubMed     Text format    

  16. PEDRAZZOLI D, Houben R, Viney K, Lonnroth K, et al
    Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB.
    Int J Tuberc Lung Dis. 2019;23:1236.
    PubMed     Text format    

  17. SYKES CA, Shepherd J, McGoldrick C, Kennedy N, et al
    A case of rifampicin-induced haemolysis.
    Int J Tuberc Lung Dis. 2019;23:239-240.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. THUONG NTT, Vinh DN, Hai HT, Thu DDA, et al
    Pre-treatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment.
    J Infect Dis. 2018 Oct 9. pii: 5123684. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Oncol

  19. LANGAN EA, Graetz V, Allerheiligen J, Zillikens D, et al
    Immune checkpoint inhibitors and tuberculosis: an old disease in a new context.
    Lancet Oncol. 2020;21:e55-e65.
    PubMed     Text format     Abstract available


    PLoS Med

  20. GUPTA A, Hughes MD, Garcia-Prats AJ, McIntire K, et al
    Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
    PLoS Med. 2019;16:e1002882.
    PubMed     Text format     Abstract available


    PLoS One

  21. JIN KW, Lee JY, Rhiu S, Choi DG, et al
    Longitudinal evaluation of visual function and structure for detection of subclinical Ethambutol-induced optic neuropathy.
    PLoS One. 2019;14:e0215297.
    PubMed     Text format     Abstract available

  22. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Text format     Abstract available

  23. GOOVAERTS O, Massinga-Loembe M, Ondoa P, Ceulemans A, et al
    Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS.
    PLoS One. 2019;14:e0215991.
    PubMed     Text format     Abstract available

  24. ERESO BM, Yimer SA, Gradmann C, Sagbakken M, et al
    Barriers for tuberculosis case finding in Southwest Ethiopia: A qualitative study.
    PLoS One. 2020;15:e0226307.
    PubMed     Text format     Abstract available

  25. ALENE KA, Viney K, Gray DJ, McBryde ES, et al
    Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
    PLoS One. 2020;15:e0227100.
    PubMed     Text format     Abstract available

  26. MORASKI GC, Deboosere N, Marshall KL, Weaver HA, et al
    Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
    PLoS One. 2020;15:e0227224.
    PubMed     Text format     Abstract available

  27. YAMAUCHI M, Kinjo T, Parrott G, Miyagi K, et al
    Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia.
    PLoS One. 2020;15:e0227636.
    PubMed     Text format     Abstract available

  28. RUIZ-GROSSO P, Cachay R, de la Flor A, Schwalb A, et al
    Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227472.
    PubMed     Text format     Abstract available

  29. MOAYEDI-NIA S, Barss L, Oxlade O, Valiquette C, et al
    The mTST - An mHealth approach for training and quality assurance of tuberculin skin test administration and reading.
    PLoS One. 2019;14:e0215240.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: